Search
Descriptor English: Aspirin, Dipyridamole Drug Combination
Descriptor Spanish: Combinación Aspirina y Dipiridamol
Descriptor combinación medicamentosa de aspirina y dipiridamol
Scope note: Combinación farmacéutica compuesta por aspirina y dipiridamol que actúa como un INHIBIDOR DE LA AGREGACIÓN PLAQUETARIA, utilizada para prevenir la TROMBOSIS y ACCIDENTE CEREBROVASCULAR en el ATAQUE ISQUÉMICO TRANSITORIO.
Descriptor Portuguese: Combinação Aspirina e Dipiridamol
Descriptor French: Association d'aspirine et de dipyridamole
Entry term(s): 3301, TX
Aggrenox
Asasantin
Asasantin Retard
Aspirin Dipyridamole Drug Combination
Aspirin-Dipyridamole Drug Combination
Combination, Aspirin-Dipyridamole Drug
Dipyridamole-Aspirin, Extended-Release
Drug Combination, Aspirin-Dipyridamole
Extended Release Dipyridamole Aspirin
Extended-Release Dipyridamole-Aspirin
Retard, Asasantin
TX 3301
TX-3301
Tree number(s): D02.455.426.559.389.657.410.595.176.500
D03.383.742.175.500
D26.310.125
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000068342
Scope note: A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Platelet Aggregation Inhibitors
Public MeSH Note: 2016; ASPIRIN-DIPYRIDAMOLE DRUG COMBINATION was indexed under ASPIRIN and DIPYRIDAMOLE 1986-2015
History Note: 2016 (1986)
DeCS ID: 55892
Unique ID: D000068342
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/27
Aspirin, Dipyridamole Drug Combination - Preferred
Concept UI M0539734
Scope note A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT ISCHEMIC ATTACK patients.
Preferred term Aspirin, Dipyridamole Drug Combination
Entry term(s) Aspirin Dipyridamole Drug Combination
Aspirin-Dipyridamole Drug Combination
Combination, Aspirin-Dipyridamole Drug
Drug Combination, Aspirin-Dipyridamole
TX 3301 - Narrower
Concept UI M0137475
Preferred term TX 3301
Entry term(s) 3301, TX
TX-3301
Extended-Release Dipyridamole-Aspirin - Narrower
Concept UI M0397744
Preferred term Extended-Release Dipyridamole-Aspirin
Entry term(s) Dipyridamole-Aspirin, Extended-Release
Extended Release Dipyridamole Aspirin
Asasantin - Narrower
Concept UI M0137473
Preferred term Asasantin
Asasantin Retard - Narrower
Concept UI M0397745
Preferred term Asasantin Retard
Entry term(s) Retard, Asasantin
Aggrenox - Narrower
Concept UI M0359403
Preferred term Aggrenox



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey